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Abstract
Background: Over the years, great efforts have been made to record the frequency of orofacial
clefts in different populations. However, very few studies were able to account for the etiological
and phenotypic heterogeneity of these conditions. Thus, data of cases with syndromic orofacial
clefts from large population-based studies are infrequent.
Methods: Clinically recognized and notified syndromes and associations including cleft lip with or
without cleft palate and other congenital anomalies were selected from the Hungarian Congenital
Abnormality Registry (HCAR) between 1973 and 1982 and prevalence rates were calculated.
Results:  Of 3,110 cases reported as having orofacial clefts, 653 had multiple congenital
abnormalities. Of these, 60 (9.2%) had a known etiology (monogenic: 25 or 3.8%, chromosomal: 31
or 4.7%, teratogenic: 4 or 0.6%). Seventy-three subjects (11.2%) had schisis in addition to the oral
cleft. Skeletal anomalies were the most common malformations among cases with cleft lip with/
without cleft palate (CL/P) and cleft palate (CP). Disorders of the central nervous system and
cardiovascular malformations were also frequently associated.
Conclusion: Surveillance systems, such as the HCAR, provide useful information about prevalence
rates of congenital anomalies in a population. However, in a field where new syndromes are being
discovered and classifications regularly updated, these rates should only be accepted as provisional.
Background
It has been known for more than 80 years that cleft lip
with or without cleft palate (CL/P) and isolated cleft pal-
ate (CP), collectively termed oral clefts (OCs), are fre-
quently associated with congenital anomalies [1]. The
prevalence of associated anomalies in subjects with OCs
varies widely, ranging from 6% to 63%; however, when
broken down by subtype, it is clear that they are much
more frequent in patients with isolated CP (13–50%)
than in patients with cleft lip (CL) (7%-13%) or patients
with cleft lip and palate (CLP) (2%-26%) [1-7]. The
sources of variation have been recently described by
Wyszynski et al. [1] as 1) differences in case definition and
inclusion/exclusion criteria, 2) how long after birth cases
are examined, 3) variability of clinical expression of asso-
ciated anomalies, 4) knowledge and technology available
to produce syndrome delineation, 5) selection of patients,
sources of ascertainment, and sample size, 6) true popula-
tion differences and changes in frequency over time.
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The evaluation of patients with multiple congenital
anomalies (MCAs) is of critical importance because 1. all
unbalanced autosomal chromosomal aberrations and
most gene mutations and teratogens produce syndromes.
Therefore, MCAs are sensitive indicators of germinal
mutagens and teratogens [8]. 2. The delineation of an
MCA-entity facilitates a better understanding of the phe-
notypic spectrum, prognosis, and origin of the condition.
The latter may be of great importance in genetic coun-
seling or to detect new teratogenic agents. 3. Gene map-
ping efforts for some of these conditions might become
feasible after the identification of informative families.
The objective of this paper is to describe the cases with
OCs and associated anomalies identified in a large popu-
lation-based birth defects registry in Hungary.
Methods
Eligible cases were newborns with OCs and at least one
other congenital anomaly identified from the records of
the nation-based "Hungarian Congenital Abnormality
Registry" (HCAR; [9]) and born between 1973 and 1982.
No data were collected after 1982. Notification by physi-
cians of cases with structural birth defects (i.e., congenital
abnormalities) to the HCAR was mandatory during that
time period. Most cases were notified by obstetricians,
since in Hungary virtually all deliveries occur in inpatient
obstetric clinics, or from pediatricians who were working
in the neonatal units of inpatient obstetric clinics and var-
ious inpatient and outpatient pediatric clinics. During the
study period, autopsy was required for all infant deaths,
and was often practiced for stillborn fetuses. Pathologists
sent a copy of each autopsy report to the HCAR if any
birth defects were identified. The recorded total (birth +
fetal) prevalence of cases with CL/P and with isolated CP
was 1.01 and 0.35 per 1,000 newborns (liveborn infants,
stillborn and malformed fetuses from electively-termi-
nated pregnancies), respectively. About 95% of cases with
CL/P and close to 90% of cases with isolated CP were
reported to the HCAR during the 10 years of the study
period [9]. Based on the available clinical notations, each
case was assigned to one of three categories:
1) Unspecified multiple congenital anomalies. These
cases had such limited information that it was not possi-
ble to differentiate the type of malformations present.
New or supplementary information was requested from
the clinicians. Of 6,641 total cases with multiple congen-
ital anomalies reported to the HCAR, 131 subjects (2.0%)
were in this category.
2) Unidentified (but specified) multiple congenital
anomalies. These cases had information about the associ-
ated anomalies, but it was not possible to distinguish
between syndrome, sequence, and association. Several
attempts were made to remediate this situation: (a) a copy
of the detailed necropsy records was requested from the
pathologist when the case expired (stillborn or infant
death). Pathology records were received in 88% of these
cases; (b) cases that listed congenital dislocation of the
hip (mainly hip dysplasia or Ortolani positivity), club-
foot, congenital inguinal hernia, or some other mild con-
genital anomaly were also part of a study on postural con-
genital anomalies [10], which provided additional
information; (c) other cases with multiple congenital
anomalies who survived the infant period were officially
referred to one of the eight Multiple Congenital Anoma-
lies Examination Centers, which functioned as part of the
HCAR. Each center had a circumscribed catchment area
and was equipped with laboratory facilities suitable to
carry out chromosome analysis, serological examinations
(ie, for rubella and cytomegalovirus, toxoplasmosis, etc.),
and certain biochemical tests. Clinical examination by a
dysmorphologist was combined with multidisciplinary
counseling concerning possible treatment and prognosis
for the patient, as well as regarding the risk of recurrence
in further pregnancies [11]; (d) occasionally, the records
had sufficient information, but no diagnosis. Of 17 cases
with OCs, four cases were eventually identified as having
a syndrome (Ectrodactyly-Ectodermal Dysplasia-CL/P,
Meckel, Mohr, and Roberts) and one had an association
(schisis) [8]. Finally, (e) cases born between 1980 and
1982 were studied further in the context of a separate epi-
demiological study carried-out between 1982 and 1983. A
structured questionnaire and an explanatory letter were
mailed to the parents of these cases soliciting information
on their children's condition. The information gathered
made it possible to confirm or modify some diagnoses. Of
6,641 total cases with multiple congenital anomalies
reported to the HCAR, 3,393 subjects (51%) had uniden-
tified but specified MCAs.
3) Identified syndromes or associations. These cases were
accepted without any further follow-up on the basis of the
clinical records. Of 6,641 total cases with multiple con-
genital anomalies reported to the HCAR, 3,117 subjects
(47%) were in this category.
Results
The dataset comprised 65,923 cases with congenital
anomalies born between 1973 and 1982. The number of
livebirths during the study period was 1,667,166, result-
ing in a prevalence of cases with congenital anomalies of
39.5 per 1,000 or ≈  4% livebirths. The number of con-
firmed cases with more than one congenital anomaly was
6,641 (prevalence at birth: 3.98 per 1,000 or 10% of all
anomalies). The stillbirth and infant death rates for cases
with multiple congenital anomalies were 8.67% and
23.8%, respectively, which are about 10 times higher than
the corresponding national figures for the study period.BMC Oral Health 2005, 5:4 http://www.biomedcentral.com/1472-6831/5/4
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Of the 6,641 cases with more than one anomaly, 2,341
had a syndrome, 776 an association, 131 were unspeci-
fied, and 3,393 were unidentified. Of the 3,110 cases with
OCs, 2,457 or ≈  80% were isolated OCs (nonsyndromic
and sequences) and 653 had multiple congenital anoma-
lies (syndromic and associations) (Table 1). In the latter
group, 60 (9.2%) had a known etiology (monogenic: 25
or 3.8%, chromosomal: 31 or 4.7%, teratogenic: 4 or
0.6%) (Table 2). There were 73 cases (11.2%) with OCs
associated to schisis. The remaining 520 cases with OCs
and other anomalies (351 CL/P and 169 CP) were uni-
dentified (verba, of unknown etiology).
Most cases with unidentified syndromic orofacial clefts
had a total of 2 malformations. There were 181 subjects
with unidentified syndromic CL/P and only 1 other mal-
formation (or 51.6% of all unidentified syndromic CL/P).
Similarly, there were 81 subjects with unidentified syn-
dromic CP and only 1 other malformation (or 47.9% of
all unidentified syndromic CP) (Table 3). In unidentified
syndromic CL/P cases, the most frequent combinations
were with anomalies of the heart or circulatory system (n
= 37, rate: 7.2/100,000 births), club foot (n = 21, rate: 3.1/
100,000 births), congenital hydrocephaly (n = 22, rate:
3.0/100,000 births), and polydactyly in hand or foot (n =
18, rate: 3.0/100,000 births). The most common combi-
nations in those with unidentified syndromic CP were
anomalies of the heart or circulatory system (n = 24, rate:
4.5/100,000 births), club foot (n = 16, rate: 2.4/100,000
births), congenital anomalies of the ear (n = 4, rate: 1.4/
100,000 births), and anomalies of the skeletal system,
especially spine, ribs, and sternum (n  = 3, rate: 1.1/
100,000 births).
There were 81 and 31 patients with a total of three con-
genital anomalies including syndromic unidentified CL/P
and CP, respectively (Table 3). In these cases, the most
common coexisting anomalies for CL/P were of the heart
and circulatory system (n = 17), polydactyly (n = 13) and
reduction of the limbs (n = 12), while only anomalies of
the heart and circulatory system were frequent among
those patients with CP (n = 11). One hundred and seventy
one subjects with unidentified CL/P and 88 with CP had
Table 1: Cases with isolated oral clefts (OCs) and with OCs plus 
other congenital anomalies in the Hungarian Congenital 
Abnormality Registry (HCAR), 1973–1982.
Category Group Number Prevalence*
Isolated
Cleft lip with or without cleft palate 
(CL/P)
1,687 1.02
Cleft lip only 607 0.36
Cleft lip and palate 1,080 0.65
Posterior cleft palate only 632 0.38
Robin sequence 99 0.06
ADAM sequence (n = 31)
including atypical oral clefts 10 0.01
Holoprosencephaly (n = 38)
including orofacial clefts 12 0.01
Others (median, oblique, etc.) 17 0.01
Subtotal 2,457 1.47
Multiple Congenital Anomalies
CL/P in recognized entities 83 0.05
CL/P in unidentified entities 351 0.21
CP in recognized entities 48 0.03
CP in unidentified entities 169 0.10
Robin sequence in recognized 
syndrome
2 0.00
Total 653 0.39
All cases 3,110 1.87
*per 1,000 livebirths
Table 2: Etiology of recognized syndromes and associations in 
the entire HCAR datatset and among the subjects with OCs.
Etiological Entity Entire 
Dataset
Subjects 
with OCs
Mendelian Syndromes
Stickler type I* 4 2
Faciogenitopopliteal 2 2
Ectrodactyly, ectodermal dysplasia, CL/P 6 6
Diastrophic displasia 2 1
Meckel 28 4
Orofaciodigital type II 5 5
Roberts 4 4
Orofaciodigital type I 9 1
Subtotal 60 25
Chromosomal
Trisomy 13 35 29
Trisomy 18 22 1
Deletions 25 1
Subtotal 82 31
Teratogenic
Hydantoin 4 4
Associations
Schisis 130 73
Total 276 133
*Stickler syndrome included Robin sequenceBMC Oral Health 2005, 5:4 http://www.biomedcentral.com/1472-6831/5/4
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four or more anomalies; however, there were few repeated
combinations:
2 cases with CL, congenital heart defect, polydactyly, and
hydrocephaly,
2 cases with CP, polydactyly, anorectal atresia/stenosis,
and branchial anomalies,
2 cases with CP, hydrocephaly, and anomalies of the skel-
etal and digestive systems, and
2 cases with CP, anomalies of the diaphragm and of the
ear and renal agenesis/dysgenesis.
Table 4 presents the frequency of malformations by
affected organ system in children with multiple congeni-
tal anomalies and orofacial clefts. Malformations of the
skeletal system were the most common in both CL/P and
CP subjects, followed by CNS and cardiovascular among
the former and cardiovascular and CNS and urogenital in
the latter.
Discussion
The main objective of this article was to present preva-
lence and baseline characteristics of cases with syndromic
OCs and associated anomalies in the HCAR dataset. The
HCAR is an excellent source of cases because it is (1) pop-
ulation-based, (2) from an ethnically homogeneous, well-
defined population, (3) with a high recorded birth preva-
lence of cases with congenital anomalies compared to
other registries (approximately 4%) indicating a nearly
complete ascertainment, and (4) the clinical diagnoses
have a high level of precision [12]. However, the HCAR
has two major weaknesses: First, the information on the
cases is based on the notification made by several thou-
sand medical doctors who have uneven experience with
children with dysmorphic features. Second, the ascertain-
Table 3: Frequency (and percentage) of anomalies in cases with non-isolated CL/P and CP of unidentified etiology.
Total Number of 
Anomalies
Unidentified Etiology CL/P Unidentified Etiology CP
2 181 51.6 81 47.9
3 8 12 3 . 13 11 8 . 3
4 4 01 1 . 42 81 6 . 6
5 21 6.0 17 10.1
6 16 4.5 8 4.7
7 or more 12 3.4 4 2.4
Total 351 100.0 169 100.0
Table 4: Frequency (and percentage of the total) of malformations by affected organ systems in subjects with multiple congenital 
anomalies.
CL/P (n = 436) CP (n = 217) Both (n = 653)
Central nervous system 158 (20.6) 44 (11.1) 202 (17.4)
Eye 36 (4.7) 7 (1.8) 44 (3.8)
Ear 32 (4.2) 23 (5.8) 55 (4.7)
Face-neck 16 (2.1) 22 (5.5) 38 (3.3)
Cardiovascular system 119 (15.6) 75 (18.9) 194 (16.7)
Respiratory system 4 (0.5) 4 (1.0) 8 (0.7)
Digestive system 51 (6.7) 30 (7.5) 81 (7.0)
Urogenital system 88 (11.5) 44 (11.1) 132 (11.3)
Skeletal (including limb deficiency) 191 (25.0) 121 (30.5) 312 (26.8)
Skin 0 (0.0) 1 (0.2) 1 (0.1)
Abdominal wall/diaphragma 46 (6.0) 15 (3.8) 61 (5.2)
Other† 24 (3.1) 11 (2.8) 35 (3.0)
Total number of 
malformations
765 397 1,162
†includes congenital inguinal hernia.BMC Oral Health 2005, 5:4 http://www.biomedcentral.com/1472-6831/5/4
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ment covered a period when many of the craniofacial syn-
dromes known today had not been yet delineated.
Of 653 cases with OCs and multiple congenital anoma-
lies, only 133 (20.4%) were part of a known etiological
entity (Table 2). Among the 60 Mendelian syndromic
cases in the entire HCAR data set, 25 included OCs
(41.7%). During the ascertainment period (1973–1982),
over 100 syndromes including OCs had been reported in
the literature [13]. However, many were not diagnosed
and/or notified to the HCAR. Two examples are the Van
der Woude syndrome, which is a relatively common auto-
somal dominant condition with CL/P [14] and is absent
in the HCAR and the oculo-auriculo-vertebral spectrum
(previously known as Goldenhar syndrome), frequently
associated with orofacial clefts, also non-existent in the
HCAR. In other cases, there seems to be an over-reporting
of certain conditions. For example, there are 28 cases of
Meckel syndrome in the HCAR, with 4 cases including
OCs, a rare combination.
The proportion of reported chromosomal abnormalities
to the HCAR is lower than expected and orofacial clefts are
no exception. This might be due to any of the following
three facts: (1) although chromosome analysis was rec-
ommended in all cases with multiple congenital anoma-
lies, this advice was rarely followed, (2) cases with
multiple congenital anomalies had a high perinatal mor-
tality and karyotyping was seldom performed in these
cases, and (3) recently developed sensitive chromosomal
diagnostic techniques, such as fluorescent in situ hybridi-
zation (FISH), were not available during the study period.
Therefore, the relatively common deletion 22q11.2 seen
in patients with OCs (previously known as velocardiofa-
cial syndrome or Di George syndrome) could not be
identified. This might explain our finding of chromo-
somal anomalies in only 4.7% of the cases with MCAs,
significantly less than other population-based studies (ie,
Tolarova and Cervenka: 8.8% [7], Stoll et al.: 7.8% [15]).
All four cases caused by teratogens were identified as fetal
hydantoin syndrome (Table 2). Fetal alcohol syndrome
was notified very rarely to the HCAR. Among cases with
diabetic embryopathy, orofacial clefts were not recorded
and therefore are not included in this report. The
collection and analysis of information on pregnancy his-
tory, including maternal drug use, would help identify
known or new syndromes caused by teratogens. This was
the main motivation for the establishment of the Case-
Control Surveillance Program of Congenital Abnormali-
ties in Hungary [9].
Of 130 cases with the schisis association, 55 (42.3%) had
CL/P and 16 had CP (12.3%). This association had been
originally described by one of us when it was noted that
there were cases with neural tube defects (anencephaly,
encephalocele, spina bifida cystica), OCs, omphalocele,
and diaphragmatic hernia associated with one another far
more frequently than at the expected random combina-
tion rates [16]. No other association with OCs was found.
The evaluation of these results suggests that the Hungar-
ian registry probably under-reported chromosomal
abnormalities. This might be due to the following: first,
the HCAR is a cross-sectional registry; thus, its is limited
in its ability to obtain detailed clinical descriptions of
each infant with a syndrome, including X-rays, karyo-
types, or screening for the 22q11.2 deletion. Second,
HCAR ascertained cases between 1973 and 1982. The
development of improved molecular and cytogenetic
tools in the 1980s, which led to the identification of the
etiology of many conditions of previously unidentified
origin, might account for some misclassification.
Conclusion
The description of component anomalies in cases with
multiple congenital anomalies may help identify recog-
nizable entities and delineate new syndromes. This
knowledge can be used to better understand the needs of
the population (ie, diagnosis, prognosis, counseling) and
to develop policies for health care. In order to be success-
ful, birth defects surveillance systems must include experi-
enced dysmorphologists up-to-date with the latest
diagnostic tools and definitions [1]. Engagement with the
large multinational registries, such as the International
Collaborative Research on Craniofacial Anomalies Project
supported by the World Health Organization (WHO)
[17], would be of benefit to all as well. It behooves the
readers to note that in the HCAR dataset, which contains
close to 66,000 congenital anomalies (4% of the total live
births), almost 10% of these had more than one anomaly
and more than half of these could not be allocated to a
particular syndrome or association. This in itself points to
the need for a global effort to improve the sensitivity and
specificity of diagnosis. It is our hope that the information
displayed in this paper will contribute to increase that
awareness.
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